The risk for developing cancer in Israeli ATM, BLM, and FANCC heterozygous mutation carriers

Euhus, 2013, Genetic predisposition syndromes and their management, Surg Clin North Am, 93, 341, 10.1016/j.suc.2013.01.005 Ford, 1998, Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium, Am J Hum Genet, 62, 676, 10.1086/301749 Weischer, 2007, Increased risk of breast cancer associated with CHEK2*1100delC, J Clin Oncol, 25, 57, 10.1200/JCO.2005.05.5160 Hollestelle, 2010, Discovering moderate-risk breast cancer susceptibility genes, Curr Opin Genet Dev, 20, 268, 10.1016/j.gde.2010.02.009 Swift, 1991, Incidence of cancer in 161 families affected by ataxia-telangiectasia, N Engl J Med, 325, 1831, 10.1056/NEJM199112263252602 Thompson, 2005, Cancer risks and mortality in heterozygous ATM mutation carriers, J Natl Cancer Inst, 97, 813, 10.1093/jnci/dji141 Ahmed, 2006, ATM and breast cancer susceptibility, Oncogene, 25, 5906, 10.1038/sj.onc.1209873 Tavtigian, 2009, Rare, evolutionarily unlikely missense substitutions in ATM confer increased risk of breast cancer, Am J Hum Genet, 85, 427, 10.1016/j.ajhg.2009.08.018 Mao, 2012, Association between ATM 5557G>A polymorphism and breast cancer risk: a meta-analysis, Mol Biol Rep, 39, 1113, 10.1007/s11033-011-0839-6 Zhang, 2011, Genetic variants associated with breast-cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence, Lancet Oncol, 12, 477, 10.1016/S1470-2045(11)70076-6 Shen, 2012, Association between ATM polymorphisms and cancer risk: a meta-analysis, Mol Biol Rep, 39, 5719, 10.1007/s11033-011-1381-2 Lu, 2011, Association between polymorphisms of the ataxia telangiectasia mutated gene and breast cancer risk: evidence from the current studies, Breast Cancer Res Treat, 126, 141, 10.1007/s10549-010-1081-y Ding, 2011, Lack of association between ATM C.1066-6T > G mutation and breast cancer risk: a meta-analysis of 8,831 cases and 4,957 controls, Breast Cancer Res Treat, 125, 473, 10.1007/s10549-010-0977-x Goss, 2002, Enhanced tumor formation in mice heterozygous for Blm mutation, Science, 297, 2051, 10.1126/science.1074340 Frank, 2010, Colorectal cancer and polymorphisms in DNA repair genes WRN, RMI1 and BLM, Carcinogenesis, 31, 442, 10.1093/carcin/bgp293 Ding, 2009, Genetic variants of BLM interact with RAD51 to increase breast cancer susceptibility, Carcinogenesis, 30, 43, 10.1093/carcin/bgn233 Sokolenko, 2012, High prevalence and breast cancer predisposing role of the BLM c.1642 C>T (Q548X) mutation in Russia, Int J Cancer, 130, 2867, 10.1002/ijc.26342 Prokofyeva, 2013, Nonsense mutation p.Q548X in BLM, the gene mutated in Bloom's syndrome, is associated with breast cancer in Slavic populations, Breast Cancer Res Treat, 137, 533, 10.1007/s10549-012-2357-1 Thompson, 2012, Exome sequencing identifies rare deleterious mutations in DNA repair genes FANCC and BLM as potential breast cancer susceptibility alleles, PLoS Genet, 8, 10.1371/journal.pgen.1002894 Bogdanova, 2015, Prevalence of the BLM nonsense mutation, p.Q548X, in ovarian cancer patients from Central and Eastern Europe, Fam Cancer, 14, 145, 10.1007/s10689-014-9748-x Antczak, 2013, A common nonsense mutation of the BLM gene and prostate cancer risk and survival, Gene, 532, 173, 10.1016/j.gene.2013.09.079 Peleg, 2002, Bloom syndrome and Fanconi's anemia: rate and ethnic origin of mutation carriers in Israel, Isr Med Assoc J, 4, 95 Gruber, 2002, BLM heterozygosity and the risk of colorectal cancer, Science, 297, 2013, 10.1126/science.1074399 Zauber, 2005, Clinical and genetic findings in an Ashkenazi Jewish population with colorectal neoplasms, Cancer, 104, 719, 10.1002/cncr.21230 Cleary, 2003, Heterozygosity for the BLM(Ash) mutation and cancer risk, Cancer Res, 63, 1769 van der Heijden, 2003, Fanconi anemia gene mutations in young-onset pancreatic cancer, Cancer Res, 63, 2585 Barber, 2003, Constitutional sequence variation in the Fanconi anaemia group C (FANCC) gene in childhood acute myeloid leukaemia, Br J Haematol, 121, 57, 10.1046/j.1365-2141.2003.04234.x Seal, 2003, Evaluation of Fanconi Anemia genes in familial breast cancer predisposition, Cancer Res, 63, 8596 Zlotogora, 2014, Genetics and genomic medicine in Israel, Mol Genet Genomic Med, 2, 85, 10.1002/mgg3.73 Peleg, 2011, The D1152H cystic fibrosis mutation in prenatal carrier screening, patients and prenatal diagnosis, J Med Screen, 18, 169, 10.1258/jms.2011.011044 Kreiss, 2000, The founder mutations in the BRCA1, BRCA2, and ATM genes in Moroccan Jewish women with breast cancer, Genet Test, 4, 403, 10.1089/109065700750065171 Fishler, 2008 Baris, 2007, Prevalence of breast and colorectal cancer in Ashkenazi Jewish carriers of Fanconi anemia and Bloom syndrome, Isr Med Assoc J, 9, 847 Gilad, 1996, Ataxia-telangiectasia: founder effect among North African Jews, Hum Mol Genet, 5, 2033, 10.1093/hmg/5.12.2033 Purcell, 2003, Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits, Bioinformatics, 19, 149, 10.1093/bioinformatics/19.1.149